Aims-(1) To study the frequency of putative malignancy associated point mutations and a 30 base pair (bp) deletion in exon 3 of the C-terminus of the EpsteinBarr virus (EBV) encoded latent membrane protein (LMP)-1 (BNLF-1) gene in wild type EBV strains. (2) To assess the influence of these mutations on the tumorigenicity of lymphoblastoid cell lines (LCL).
Methods-Eight spontaneous EBV (wild type) infected LCL were established from seven subjects. Deletions and single base mutations in the C-terminus of the BNLF-1 gene were demonstrated using bi-directional solid phase dideoxy sequencing following PCR amplification of viral DNA from the LCL. Tumorigenicity ofthe LCL was assessed in SCID and nude mice. Serum dependent growth and ability to form colonies in soft agarose were assessed for representative LCL. Results-All LCL showed sequence differences compared with the prototypic EBV strain B95-8. The 30 bp deletion could be detected in three of eight LCL and a 69 bp deletion (including the 30 bp deletion) was identified in an additional LCL. A range of single base mutations (including those described previously in association with EBV related neoplasias) was also seen in some of the LCL. In transformation studies, the genetic variations did not seem to influence the in vitro behaviour of the LCL. In the tumorigenicity studies, the presence of the 30 bp deletion had no influence on the behaviour of the LCL which were, as expected, tumorigenic in SCID mice but not in nude mice. In contrast, the LCL carrying the 69 bp deletion was tumorigenic in both SCID and nude mice.
Conclusions-Genetic changes described previously in the C-terminus of the LMP-1 gene in various malignancy derived EBV strains are also presetit frequently in wild type viruses and do not simply define tumour specific EBV strains. Changes within this region may, however, still be important for the tumorigenicity of LMP-1 and thus play a role in EBV oncogenesis. 
Epstein-Barr virus (EBV) is a human herpes virus that causes infectious mononucleosis'
and is associated with various malignancies, including nasopharyngeal carcinoma, Burkitt's lymphoma, Hodgkin's disease, peripheral T cell lymphomas, and lymphoproliferative disorders in immunosuppressed patients. [2] [3] [4] [5] [6] [7] In vitro, EBV transformed lymphoblastoid cell lines (LCL) can be established by spontaneous outgrowth of EBV infected B cells from the peripheral blood of seropositive subjects.8 LCL consistently display a restricted pattern of EBV gene products (recently designated latency type III), characterised by the expression of EBV nuclear antigen (EBNA)-1, EBNA-2, EBNA-3a, b and c, and EBNA-LP, latent membrane protein (LMP)-1 and LMP2a/b, and EBV small nuclear RNAs (EBERs)-1/2.9 LMP-1 plays an important part in EBV induced cell transformation. Among other things, it is essential for the transformation of primary B cells,'" it can transform rodent fibroblasts and human keratinocytes," 12 inhibit human epithelial cell differentiation, '3 and Cell pellets from cell cultures and tumour tissue from SCID and nude mice were snap frozen. Sections were cut and stained using APAAP immunohistology. The LCL from both cultures and tumours were characterised as B cells using monoclonal antibodies directed against CD19, CD20 and CD21. The sections were also stained for activation markers intracellular adhesion molecule-1 (ICAM-1) (CD54), LFA-3 (CD58) and CD23, and for bcl-2. Expression of EBV gene products was demonstrated using the monoclonal antibodies PE2 (EBNA-2), CS. 
BI-DIRECTIONAL SOLID PHASE DIDEOXY SEQUENCING
Sequence analysis was performed to demonstrate the size and the location of deletions, and to detect single base mutations, as described recently. 22 Briefly, in all cases two parallel PCRs were performed, one for sequencing the sense strand and one for sequencing the antisense strand. The PCR product for sequencing the sense strand was produced with a nonbiotinylated sense primer and a 5' biotinylated antisense primer. The product for sequencing the antisense strand was produced with a nonbiotinylated antisense primer and a 5' biotinylated sense primer (the same primers as used to amplify the PCR product). After PCR the amplified fragments were captured from 35-50 p1 of the reaction mix (the amount needed for sequencing was estimated by electrophoresis), with 30 TTG ACG GAA GAG GTT GAA AAC AAA GGA GGT GAC CAG GGC  CAO AATTG ACG GAA GAG GTT G AAC AAA GGA GGT GAC G GGC  1851 CAA TTG ACG GAA GAG GTT CAA AAC AAA GGA GGT GAC CAG GGC  1874 CAA TTG ACG  1844 CAA TTG ACG  1858 GAA TTG  1847 AATTG  1845 AATTG  1533 AATTG   ACG  ACG  ACG  ACG   336  CCG  CCG  CCG  GAA GAG GTT CAA AAC AAA GGA GGT GAC CAG GGC CCG  GAA GAG GTT CAA AAC AAA GGA GGT GAC CAG GGC CCG  GAA GAG GTT GAA AAC AAA GGA GGT GAC G GGC CCG  GAA GAG GTT GAA AAC ACA GGA GGT GAC O GGC CCG  GAA GAG GTT GAA AAC AAA GGA GGT GAC G AGC CCG  GAA GAG GTT GAA AAC ACA GGA GGT GAC O GGC CCG   337 338+ 339  CCT TTG ATG  CCT T  ATG  CCT TTG ATG  CCT TTG ATG  CCT TTG ATG  CCT T  ATG  CCT T  ATG  CCT T  ATG  CCT T  ATG   340 341 342-343 344  ACA GAC GGA GGC GGC  ACA GAC G GGC GGC  ACA GAC GGA GGC GGC  ACA GAC GGA GGC GGC  ACA GAC GGA GGC GGC  ACA GAC GGGGC GGC  ACA GAC G  GGCGGC  ACA GAC  GGC GGC  ACA GAC  GGC GGC  1859 GAA TTG The top layer was either 0.2%, 0.3%, 0.45%, or 0.6% agarose in 1.5 ml ofthe same medium as used for the base layer; 3000 cells were added per well from one of the following cell lines: MS1845, MS1851, MS1858 or MS1859. After setting, the agarose was covered with 1 ml medium. All culture dishes were incubated at 37°C in 5% CO2. Three independent experiments were carried out and each cell line was plated in triplicate. A colony was defined as a cluster consisting of more than 10 cells. The results are summarised in fig 1. In the three cases with electrophoretical evidence of a deletion around 30 bp, sequence analysis confirmed the size to be 30 bp. Examination of the sequence environment surrounding the 30 bp deletion revealed two 9 bp repeats (GGCG-GCGGT) coding for three Gly residues (amino acids 343 to 345 and amino acids 353 to 355). We have proposed previously that the 30 bp deletion can be generated by slipped mispairing of direct repeats. 22 The sequence analysis suggests that this has probably been preceded by a single base mutation in amino acid 342 (A to T) giving two 10 bp repeats (TGGCGGCGGT; third base of the coding triplet of amino acids 342 to 345 and third base of the coding triplet of amino acids 352 to 355), one of which is included in the 30 bp deletion (fig 1) . Indeed, one of the LCL without the deletion (MS 1858) has this mutation at amino acid 342. In addition, this cell line has a mutation in the coding triplet for amino acid 352 (A to G), giving two 11 bp repeats adjacent to the 30 bp deletion, a change that would further increase the likelihood of a deletion occurring by slipped mispairing. Thus, there is circumstantial evidence that both of these mutations may be present prior to the deletion of the 30 bp sequence.
Results
In the MS 1859 LCL with electrophoretical evidence of a deletion larger than 30 bp, sequence analysis revealed a 69 bp deletion comprising the sequence of the 30 bp deletion and a further 39 bp. The sequence environment of the 69 bp deletion contains two five nucleotide repeats (GGTGA), one of which is included in the 69 bp deletion (fig 1) .
Six of the seven single base mutations detected in the CAO BNLF-1 gene between amino acids 322 and 388 were found in all 1) . Three of the LCL without deletions (MS1851, MS1874 and MS1844) showed a nucleotide sequence identical with B95.8 except for amino acid 328 (G to C: Glu to Gln) and amino acid 366 (T to A: Ser to Thr). The fourth cell line (MS 1858) contained mutations at amino acids 322 (C to G: Gln to Glu) and 352 (A to G: His to Arg) (fig 1) , together with the single base mutations affecting amino acids 334, 338, 342, and 366 detected in the CAO BNLF-1 gene and in the three LCL with the 30 bp deletion. In the sequence from amino acids 366 to 388 no single base mutations were detected in any of the LCL (data not shown). The ability to form colonies in soft agarose with low agarose concentrations (0.2% and 0.3%) was not associated with the presence of proportional to the distance between them.4' As a consequence of this the 69 bp deletion should be generated much less frequently than the 30 bp deletion.
In conclusion, these results and our recently published data on Hodgkin's disease, peripheral T cell lymphoma and infectious mononucleosis show that mutations in the C-terminal region of the BNLF-1 gene occur frequently in both malignant and benign EBV infected cells and are more widespread among wild type EBV strains than originally thought.22 While these mutations clearly do not simply define tumour specific EBV strains, our study suggests that the LMP-1 amino acid sequence 334-356 (or part of this sequence) is of importance for the tumorigenic effects of LMP-1, and that changes in the function of LMP1 may result in altered tumorigenicity of EBV infected LCL. Studies on larger numbers of LCL from normal EBV seropositive subjects are needed to investigate which mutations occur regularly in the BNLF-1 gene. Further mutational studies in vitro are needed to define the effect of the 69 bp deletion described in this study.
